Haas, Katja <br/><br/>
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.  [electronic resource] 

 -  Genes, chromosomes & cancer  Apr 2008 
 - 288-98 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-2264 
<br/><br/><label>Standard No.: </label>10.1002/gcc.20532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5' Untranslated Regions--genetics<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Case-Control Studies<br/>Chromosomes, Human, Pair 3--genetics<br/>DNA-Binding Proteins--genetics<br/>Female<br/>Gene Expression Regulation, Leukemic--physiology<br/>Gene Rearrangement<br/>Humans<br/>Leukemia, Myeloid, Acute--genetics<br/>MDS1 and EVI1 Complex Locus Protein<br/>Male<br/>Middle Aged<br/>Oncogene Proteins, Fusion--genetics<br/>Polymerase Chain Reaction<br/>Prognosis<br/>Proto-Oncogenes--genetics<br/>RNA, Messenger--genetics<br/>Remission Induction<br/>Retrospective Studies<br/>Survival Rate<br/>Transcription Factors--genetics<br/>Treatment Outcome